XETRMCE
Market cap235mUSD
Sep 25, Last price
13.70EUR
Name
MEDIQON Group AG
Chart & Performance
Profile
MEDIQON Group AG, together with its subsidiaries, provides software solutions in the DACH region. It offers management software; practice management software for veterinarians; and a modular software solution for sheet metal processing companies; and building related services. The company develops and sells software solutions for construction process; software solution for standard functions of enterprise resource planning, such as sales, procurement, storage, CRM, financial accounting, etc.; ERP software for medium-sized companies; and Atlantis, a school administration software. In addition, it operates a language school; and imports and distributes cable protection products, as well as engages in planning, advising, and construction in the field of refrigeration and air conditioning technology, and air purification. The company was formerly known as medical Columbus AG. MEDIQON Group AG was founded in 1998 and is based in Königstein, Germany.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | |||||||||
Revenues | 42,067 46.80% | 28,655 | |||||||
Cost of revenue | 3,511 | 2,953 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 38,556 | 25,702 | |||||||
NOPBT Margin | 91.65% | 89.69% | |||||||
Operating Taxes | 803 | 635 | |||||||
Tax Rate | 2.08% | 2.47% | |||||||
NOPAT | 37,753 | 25,066 | |||||||
Net income | (6,604) 204.30% | (2,170) | |||||||
Dividends | (16,357) | ||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (4) | 254 | |||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | |||||||||
Long-term debt | 64,073 | 53,368 | |||||||
Deferred revenue | 1,262 | 908 | |||||||
Other long-term liabilities | 5,402 | 2,865 | |||||||
Net debt | 37,794 | 42,275 | |||||||
Cash flow | |||||||||
Cash from operating activities | 5,693 | 2,874 | |||||||
CAPEX | (2,020) | (1,723) | |||||||
Cash from investing activities | (53,212) | (47,401) | |||||||
Cash from financing activities | 58,776 | 47,060 | |||||||
FCF | 33,311 | ||||||||
Balance | |||||||||
Cash | 26,278 | 11,094 | |||||||
Long term investments | |||||||||
Excess cash | 24,175 | 9,661 | |||||||
Stockholders' equity | 1,860 | 2,678 | |||||||
Invested Capital | 161,055 | 96,298 | |||||||
ROIC | 29.34% | 26.03% | |||||||
ROCE | 23.02% | 25.09% | |||||||
EV | |||||||||
Common stock shares outstanding | 16,067 | 11,162 | |||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | 46,546 | 30,869 | |||||||
EV/EBITDA | |||||||||
Interest | 2,629 | 2,235 | |||||||
Interest/NOPBT | 6.82% | 8.70% |